Reply to the Letter to the Editor: Aflibercept in Diabetic Macular Edema Refractory to Previous Bevacizumab: Outcomes and Predictors of Success
AuthID
P-00N-QBT
P-00N-QBT
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service